NIO's New ES8 Achieves Sixth Consecutive Month as Top-Selling Large SUV with May Retail Sales of 11,472 Units

Stock News
昨天

According to the latest market data from the China Passenger Car Association, the retail sales volume for the new ES8 from NIO Inc. (NYSE: NIO) reached 11,472 units in May 2026.

This marks the sixth consecutive month the model has secured the top sales position in both the large SUV segment and the market for vehicles priced above 400,000 yuan.

Since November 2025, the new ES8 has achieved monthly retail sales exceeding 10,000 units for seven straight months.

In May, it stood as the only model in the large SUV and premium 400,000-yuan-plus categories to surpass this sales threshold.

The phenomenal market performance of the new ES8 further cements its dominant position in the high-end pure-electric SUV market.

Since deliveries commenced on September 21, 2025, the new ES8 reached the milestone of 110,000 cumulative deliveries in just 245 days.

This achievement continues to set new sales and delivery records for high-end passenger car models priced above 400,000 yuan in the Chinese market.

The robust sales momentum of the new ES8 signals that the golden era for large, three-row pure-electric SUVs has arrived.

From now until July 31, 2026, customers who place an order for the new ES8 and successfully lock it in will be eligible for a limited-time offer.

This includes a complimentary First Class Zero Gravity Seat for the driver, a five-year free subscription to the NOP+ full-scenario navigation assist system, and a First Class Cabin five-piece accessory set.

Furthermore, purchasing customers can apply for a 60-month installment financing plan provided by NIO's designated partner institutions.

The plan features a 0% down payment option, with a 0% annualized rate for the first 36 months and a 3% annualized rate for the subsequent 24 months.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10